IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Acuta Capital Partners, LLC

Q4 2017 Holdings

Filed 2018-02-14 | 74 holdings | $51.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↑Shares% Portfolio
Seattle Genetics IncCallCOM812578102$4.3K80,0000.0%
Momenta Pharmaceuticals Inc(MNTA)COM60877T100$4.3K311,1690.0%
Ishares TR(FXI)PutCHINA LG-CAP ETF464287184$4.6K100,0000.0%
Evolent Health Inc(EVH)CL A30050B101$5.2K420,0000.0%
Avexis IncCOM05366U100$5.9K52,9000.0%
Catalyst Biosciences IncCOM NEW14888D208$6.1K450,0000.0%
Edge Therapeutics IncCOM279870109$8.8K943,9060.0%
Zogenix IncCOM NEW98978L204$12.0K300,0000.0%
Intec Pharma LTD JerusalemSHSM53644106$14.0K2,724,2830.0%
Chembio Diagnostics Inc(CEMIUSD)COM NEW163572209$14.1K1,721,2990.0%
Iridex Corp(IRIX)COM462684101$15.2K2,000,0000.0%
Viewray Inc(VRAYQ)COM92672L107$17.7K1,915,6540.0%
Kadmon Hldgs Inc(KDMN)COM48283N106$17.8K4,915,0000.0%
Veracyte Inc(VCYT)COM92337F107$21.5K3,295,1110.0%
Spdr Series Trust(XBI)PutS&P BIOTECH78464A870$29.7K350,0000.1%
Iovance Biotherapeutics Inc(IOVA)COM462260100$31.1K3,892,0000.1%
Ishares TR(IWM)PutRUSSELL 2000 ETF464287655$38.1K250,0000.1%
Assembly Biosciences IncCOM045396108$49.2K1,087,1040.1%
Immunomedics Inc(IMMU)COM452907108$109.1K6,750,0000.2%
Aclaris Therapeutics Inc(ACRS)COM00461U105$2.3M92,5004.4%
Acadia Pharmaceuticals Inc(ACAD)COM004225108$2.7M90,0005.3%
Biocryst Pharmaceuticals(BCRX)COM09058V103$4.4M900,0008.6%
Argenx SE(ARGX)SPONSORED ADR04016X101$20.4M323,00039.6%
Ascendis Pharma A S(ASND)SPONSORED ADR04351P101$21.3M531,00041.3%
PreviousPage 2 of 2